[Influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis].
OBJECTIVE
To observe the influence of Xianglingwan on dysmenorrhea and serum CA125 in treating patients with endometriosis.


METHODS
A total of 54 patients with endometriosis and without medical complications were random selected. Xianglingwan was administered from the fifth day of the menstrual cycle for 3 weeks every month as a therapeutic course, and three months for a therapeutic period. Pelvic type B ultrasonograph and blood CA125 were detected before and after treatment. Visual analogue scale was admitted to evaluate the dysmenorrhea.


RESULTS
The serum CA125 reduced obviously after therapy. There was a significant difference between them (P < 0.01). The symptom of dysmenorrhea also reduced obviously after treatment. There was a significant difference between them (P < 0.05).


CONCLUSIONS
Xianglingwan can treat edometriosis effectively, and has less adverse reactions, it can also reduce the symptom of dysmenorrheal and the serum CA125.
Yang
Chun-Bo
CB
Affiliated Obsretrics and Gynecology Hospital, College of Medicine, Zhejiang University, Hangzhou 310006, China.
Chen
Yi
Y
Jin
Hang-Mei
HM
Ying
Wei-Wen
WW
D000328:Adult; D018394:CA-125 Antigen / Q000097:blood*; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D004412:Dysmenorrhea / Q000097:blood* / Q000188:drug therapy*; D004715:Endometriosis / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans
D018394:CA-125 Antigen; D004365:Drugs, Chinese Herbal